A detailed history of Daiwa Securities Group Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 486 shares of RLAY stock, worth $2,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
486
Previous 486 -0.0%
Holding current value
$2,055
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$14.16 - $24.02 $1,146 - $1,945
81 Added 20.0%
486 $7,000
Q2 2022

Aug 09, 2022

BUY
$13.31 - $34.88 $1,171 - $3,069
88 Added 27.76%
405 $7,000
Q3 2021

Nov 05, 2021

BUY
$29.75 - $37.99 $4,403 - $5,622
148 Added 87.57%
317 $10,000
Q4 2020

Feb 04, 2021

BUY
$35.51 - $54.03 $6,001 - $9,131
169 New
169 $7,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.